ALBANY, N.Y., Dec. 05, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma Outlook. The full list can be viewed in the November 2023 edition of the India Pharma Outlook magazine. This recognition acknowledges [...]
TURIN, Italy, Dec. 05, 2023 (Korea Bizwire) – The Yacht Club de Monaco and the Royal Selangor Yacht Club signed a MoU (Memorandum of Understanding) on November 27th in Kuala Lumpur to strengthen the relations between the two Clubs. Following the signing in 2008 of a reciprocity agreement between Yacht Club de Monaco, whose President [...]
With its targeted multimodal approach, NeuroAiD™II offers a broad range of therapeutic benefits to TBI patients. NeuroAiD™II was well-tolerated by TBI patients with a favourable safety profile. SINGAPORE, Dec. 04, 2023 (Korea Bizwire) – Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course [...]
Dubai, United Arab Emirates, Dec. 04, 2023 (Korea Bizwire) – The UN Global Compact, together with the UN Environment Programme (UNEP), and UN Climate Change (UNFCCC), brought together senior executives of business, industry, finance, civil society, the United Nations and Government at the 11th High-Level Meeting of Caring for Climate at COP28. Those present discussed [...]
Artist’s “Graffiti Collection” debuts at the new XO Palm Beach lounge, in a first-ever private airport lounge takeover Palm Beach, Florida December 4, 2023 (Korea Bizwire): XO, the world’s premier private aviation network, has announced an exclusive partnership with Romero Britto, considered to be the most licensed artist in the world, to celebrate innovation and creativity. [...]
Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the [...]
A Media Snippet accompanying this announcement is available by clicking on this link. Most successful dinosaur exhibit of all-time More than 1.5 million visitors see Barbara and Peter – a world-first male & female T. rex pairing Barbara is one of only three female T. rex specimens ever discovered Auckland Museum breaks new ground by [...]
MANAMA, Bahrain, Dec. 02, 2023 (Korea Bizwire) — Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after [...]
SHANGHAI, China, Dec. 01, 2023 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Therapeutic Goods Administration of the Australian Government Department of Health and Aged Care (TGA) has accepted the New [...]
VANCOUVER, British Columbia, Nov. 30, 2023 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 42nd Annual J.P. Morgan Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings on January 8-11, 2024 and a corporate presentation on January 11th, [...]